LexDanaLexDanabeta
Inventor

Cheng-ke LI

Inventor
TW

Overview

3→
Patents
2022–2024
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07KPeptides33%
PatentTitleYear
12,054,561Anti-angiogenesis fusion protein and uses thereof202411,518,819Anti-angiogenesis fusion protein and uses thereof202211,390,677Human anti-CD47 antibodies and uses thereof2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2024Patents assigned to TRICAN BIOTECHNOLOGY CO LTD (3)· patent assignee history
2022–2024Based in TW· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
TRICAN BIOTECHNOLOGY CO LTD32022–2024
Locations
LocationPatentsSpan
TW32022–2024